img

Global Pharmaceutical Intermediates Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pharmaceutical Intermediates Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Pharmaceutical Intermediates report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharmaceutical Intermediates market is projected to reach US$ 280690 million in 2034, increasing from US$ 182100 million in 2022, with the CAGR of 6.3% during the period of 2024 to 2034. Demand from Antibiotics and Antipyretic Analgesics are the major drivers for the industry.
Global Pharmaceutical Intermediates key players include Wartsila, Hyundai, MAN, MES, Caterpillar, etc. Global top three manufacturers hold a share over 45%.
China is the largest production area, with a share about 30%, followed by India and North America, both have a share over 40 percent.
In terms of product, GMP is the largest segment, with a share over 80%. And in terms of application, the largest application is Antibiotics, followed by Antipyretic analgesics, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmaceutical Intermediates market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Lonza
Catalent
Patheon
Jubilant
Granules
Ganesh
Chemcon
BASF
Porton
Lianhetech
ABA Chem
Tianma
Jiujiujiu
Alpha
Jiuzhou
Yongtai
Segment by Type
GMP
Non-GMP

Segment by Application


Antibiotics
Antipyretic Analgesics
Vitamins
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharmaceutical Intermediates market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pharmaceutical Intermediates, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pharmaceutical Intermediates industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pharmaceutical Intermediates in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pharmaceutical Intermediates introduction, etc. Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pharmaceutical Intermediates market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Pharmaceutical Intermediates Market Overview
1.1 Pharmaceutical Intermediates Product Overview
1.2 Pharmaceutical Intermediates Market Segment by Type
1.2.1 GMP
1.2.2 Non-GMP
1.3 Global Pharmaceutical Intermediates Market Size by Type
1.3.1 Global Pharmaceutical Intermediates Market Size Overview by Type (2018-2034)
1.3.2 Global Pharmaceutical Intermediates Historic Market Size Review by Type (2018-2024)
1.3.3 Global Pharmaceutical Intermediates Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pharmaceutical Intermediates Sales Breakdown by Type (2018-2024)
1.4.2 Europe Pharmaceutical Intermediates Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Pharmaceutical Intermediates Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Pharmaceutical Intermediates Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Pharmaceutical Intermediates Sales Breakdown by Type (2018-2024)
2 Global Pharmaceutical Intermediates Market Competition by Company
2.1 Global Top Players by Pharmaceutical Intermediates Sales (2018-2024)
2.2 Global Top Players by Pharmaceutical Intermediates Revenue (2018-2024)
2.3 Global Top Players by Pharmaceutical Intermediates Price (2018-2024)
2.4 Global Top Manufacturers Pharmaceutical Intermediates Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pharmaceutical Intermediates Market Competitive Situation and Trends
2.5.1 Pharmaceutical Intermediates Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Pharmaceutical Intermediates Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2022)
2.7 Date of Key Manufacturers Enter into Pharmaceutical Intermediates Market
2.8 Key Manufacturers Pharmaceutical Intermediates Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pharmaceutical Intermediates Status and Outlook by Region
3.1 Global Pharmaceutical Intermediates Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Pharmaceutical Intermediates Historic Market Size by Region
3.2.1 Global Pharmaceutical Intermediates Sales in Volume by Region (2018-2024)
3.2.2 Global Pharmaceutical Intermediates Sales in Value by Region (2018-2024)
3.2.3 Global Pharmaceutical Intermediates Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Pharmaceutical Intermediates Forecasted Market Size by Region
3.3.1 Global Pharmaceutical Intermediates Sales in Volume by Region (2024-2034)
3.3.2 Global Pharmaceutical Intermediates Sales in Value by Region (2024-2034)
3.3.3 Global Pharmaceutical Intermediates Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Pharmaceutical Intermediates by Application
4.1 Pharmaceutical Intermediates Market Segment by Application
4.1.1 Antibiotics
4.1.2 Antipyretic Analgesics
4.1.3 Vitamins
4.1.4 Others
4.2 Global Pharmaceutical Intermediates Market Size by Application
4.2.1 Global Pharmaceutical Intermediates Market Size Overview by Application (2018-2034)
4.2.2 Global Pharmaceutical Intermediates Historic Market Size Review by Application (2018-2024)
4.2.3 Global Pharmaceutical Intermediates Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pharmaceutical Intermediates Sales Breakdown by Application (2018-2024)
4.3.2 Europe Pharmaceutical Intermediates Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Pharmaceutical Intermediates Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Pharmaceutical Intermediates Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Pharmaceutical Intermediates Sales Breakdown by Application (2018-2024)
5 North America Pharmaceutical Intermediates by Country
5.1 North America Pharmaceutical Intermediates Historic Market Size by Country
5.1.1 North America Pharmaceutical Intermediates Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Pharmaceutical Intermediates Sales in Volume by Country (2018-2024)
5.1.3 North America Pharmaceutical Intermediates Sales in Value by Country (2018-2024)
5.2 North America Pharmaceutical Intermediates Forecasted Market Size by Country
5.2.1 North America Pharmaceutical Intermediates Sales in Volume by Country (2024-2034)
5.2.2 North America Pharmaceutical Intermediates Sales in Value by Country (2024-2034)
6 Europe Pharmaceutical Intermediates by Country
6.1 Europe Pharmaceutical Intermediates Historic Market Size by Country
6.1.1 Europe Pharmaceutical Intermediates Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Pharmaceutical Intermediates Sales in Volume by Country (2018-2024)
6.1.3 Europe Pharmaceutical Intermediates Sales in Value by Country (2018-2024)
6.2 Europe Pharmaceutical Intermediates Forecasted Market Size by Country
6.2.1 Europe Pharmaceutical Intermediates Sales in Volume by Country (2024-2034)
6.2.2 Europe Pharmaceutical Intermediates Sales in Value by Country (2024-2034)
7 Asia-Pacific Pharmaceutical Intermediates by Region
7.1 Asia-Pacific Pharmaceutical Intermediates Historic Market Size by Region
7.1.1 Asia-Pacific Pharmaceutical Intermediates Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Pharmaceutical Intermediates Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Pharmaceutical Intermediates Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Pharmaceutical Intermediates Forecasted Market Size by Region
7.2.1 Asia-Pacific Pharmaceutical Intermediates Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Pharmaceutical Intermediates Sales in Value by Region (2024-2034)
8 Latin America Pharmaceutical Intermediates by Country
8.1 Latin America Pharmaceutical Intermediates Historic Market Size by Country
8.1.1 Latin America Pharmaceutical Intermediates Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Pharmaceutical Intermediates Sales in Volume by Country (2018-2024)
8.1.3 Latin America Pharmaceutical Intermediates Sales in Value by Country (2018-2024)
8.2 Latin America Pharmaceutical Intermediates Forecasted Market Size by Country
8.2.1 Latin America Pharmaceutical Intermediates Sales in Volume by Country (2024-2034)
8.2.2 Latin America Pharmaceutical Intermediates Sales in Value by Country (2024-2034)
9 Middle East and Africa Pharmaceutical Intermediates by Country
9.1 Middle East and Africa Pharmaceutical Intermediates Historic Market Size by Country
9.1.1 Middle East and Africa Pharmaceutical Intermediates Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Pharmaceutical Intermediates Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Pharmaceutical Intermediates Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Pharmaceutical Intermediates Forecasted Market Size by Country
9.2.1 Middle East and Africa Pharmaceutical Intermediates Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Pharmaceutical Intermediates Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Lonza
10.1.1 Lonza Company Information
10.1.2 Lonza Introduction and Business Overview
10.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Lonza Pharmaceutical Intermediates Products Offered
10.1.5 Lonza Recent Development
10.2 Catalent
10.2.1 Catalent Company Information
10.2.2 Catalent Introduction and Business Overview
10.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Catalent Pharmaceutical Intermediates Products Offered
10.2.5 Catalent Recent Development
10.3 Patheon
10.3.1 Patheon Company Information
10.3.2 Patheon Introduction and Business Overview
10.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Patheon Pharmaceutical Intermediates Products Offered
10.3.5 Patheon Recent Development
10.4 Jubilant
10.4.1 Jubilant Company Information
10.4.2 Jubilant Introduction and Business Overview
10.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Jubilant Pharmaceutical Intermediates Products Offered
10.4.5 Jubilant Recent Development
10.5 Granules
10.5.1 Granules Company Information
10.5.2 Granules Introduction and Business Overview
10.5.3 Granules Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Granules Pharmaceutical Intermediates Products Offered
10.5.5 Granules Recent Development
10.6 Ganesh
10.6.1 Ganesh Company Information
10.6.2 Ganesh Introduction and Business Overview
10.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Ganesh Pharmaceutical Intermediates Products Offered
10.6.5 Ganesh Recent Development
10.7 Chemcon
10.7.1 Chemcon Company Information
10.7.2 Chemcon Introduction and Business Overview
10.7.3 Chemcon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Chemcon Pharmaceutical Intermediates Products Offered
10.7.5 Chemcon Recent Development
10.8 BASF
10.8.1 BASF Company Information
10.8.2 BASF Introduction and Business Overview
10.8.3 BASF Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.8.4 BASF Pharmaceutical Intermediates Products Offered
10.8.5 BASF Recent Development
10.9 Porton
10.9.1 Porton Company Information
10.9.2 Porton Introduction and Business Overview
10.9.3 Porton Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Porton Pharmaceutical Intermediates Products Offered
10.9.5 Porton Recent Development
10.10 Lianhetech
10.10.1 Lianhetech Company Information
10.10.2 Lianhetech Introduction and Business Overview
10.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Lianhetech Pharmaceutical Intermediates Products Offered
10.10.5 Lianhetech Recent Development
10.11 ABA Chem
10.11.1 ABA Chem Company Information
10.11.2 ABA Chem Introduction and Business Overview
10.11.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.11.4 ABA Chem Pharmaceutical Intermediates Products Offered
10.11.5 ABA Chem Recent Development
10.12 Tianma
10.12.1 Tianma Company Information
10.12.2 Tianma Introduction and Business Overview
10.12.3 Tianma Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Tianma Pharmaceutical Intermediates Products Offered
10.12.5 Tianma Recent Development
10.13 Jiujiujiu
10.13.1 Jiujiujiu Company Information
10.13.2 Jiujiujiu Introduction and Business Overview
10.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Jiujiujiu Pharmaceutical Intermediates Products Offered
10.13.5 Jiujiujiu Recent Development
10.14 Alpha
10.14.1 Alpha Company Information
10.14.2 Alpha Introduction and Business Overview
10.14.3 Alpha Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Alpha Pharmaceutical Intermediates Products Offered
10.14.5 Alpha Recent Development
10.15 Jiuzhou
10.15.1 Jiuzhou Company Information
10.15.2 Jiuzhou Introduction and Business Overview
10.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Jiuzhou Pharmaceutical Intermediates Products Offered
10.15.5 Jiuzhou Recent Development
10.16 Yongtai
10.16.1 Yongtai Company Information
10.16.2 Yongtai Introduction and Business Overview
10.16.3 Yongtai Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Yongtai Pharmaceutical Intermediates Products Offered
10.16.5 Yongtai Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pharmaceutical Intermediates Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pharmaceutical Intermediates Industrial Chain Analysis
11.4 Pharmaceutical Intermediates Market Dynamics
11.4.1 Pharmaceutical Intermediates Industry Trends
11.4.2 Pharmaceutical Intermediates Market Drivers
11.4.3 Pharmaceutical Intermediates Market Challenges
11.4.4 Pharmaceutical Intermediates Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pharmaceutical Intermediates Distributors
12.3 Pharmaceutical Intermediates Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of GMP
Table 2. Major Company of Non-GMP
Table 3. Global Pharmaceutical Intermediates Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Pharmaceutical Intermediates Sales by Type (2018-2024) & (K MT)
Table 5. Global Pharmaceutical Intermediates Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Pharmaceutical Intermediates Sales by Type (2018-2024) & (US& Million)
Table 7. Global Pharmaceutical Intermediates Market Share in Value by Type (2018-2024)
Table 8. Global Pharmaceutical Intermediates Price by Type (2018-2024) & (USD/MT)
Table 9. Global Pharmaceutical Intermediates Sales by Type (2024-2034) & (K MT)
Table 10. Global Pharmaceutical Intermediates Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Pharmaceutical Intermediates Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Pharmaceutical Intermediates Sales Market Share in Value by Type (2024-2034)
Table 13. Global Pharmaceutical Intermediates Price by Type (2024-2034) & (USD/MT)
Table 14. North America Pharmaceutical Intermediates Sales by Type (2018-2024) & (K MT)
Table 15. North America Pharmaceutical Intermediates Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Pharmaceutical Intermediates Sales (K MT) by Type (2018-2024)
Table 17. Europe Pharmaceutical Intermediates Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Pharmaceutical Intermediates Sales (K MT) by Type (2018-2024)
Table 19. Asia-Pacific Pharmaceutical Intermediates Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Pharmaceutical Intermediates Sales (K MT) by Type (2018-2024)
Table 21. Latin America Pharmaceutical Intermediates Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Pharmaceutical Intermediates Sales (K MT) by Type (2018-2024)
Table 23. Middle East and Africa Pharmaceutical Intermediates Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Pharmaceutical Intermediates Sales by Company (2018-2024) & (K MT)
Table 25. Global Pharmaceutical Intermediates Sales Share by Company (2018-2024)
Table 26. Global Pharmaceutical Intermediates Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Pharmaceutical Intermediates Revenue Share by Company (2018-2024)
Table 28. Global Market Pharmaceutical Intermediates Price by Company (2018-2024) & (USD/MT)
Table 29. Global Pharmaceutical Intermediates Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Pharmaceutical Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2022)
Table 32. Date of Key Manufacturers Enter into Pharmaceutical Intermediates Market
Table 33. Key Manufacturers Pharmaceutical Intermediates Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Pharmaceutical Intermediates Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Pharmaceutical Intermediates Sales by Region (2018-2024) & (K MT)
Table 37. Global Pharmaceutical Intermediates Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Pharmaceutical Intermediates Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Pharmaceutical Intermediates Sales Market Share in Value by Region (2018-2024)
Table 40. Global Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 41. Global Pharmaceutical Intermediates Sales by Region (2024-2034) & (K MT)
Table 42. Global Pharmaceutical Intermediates Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Pharmaceutical Intermediates Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Pharmaceutical Intermediates Sales Market Share in Value by Region (2024-2034)
Table 45. Global Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 46. Global Pharmaceutical Intermediates Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Pharmaceutical Intermediates Sales by Application (2018-2024) & (K MT)
Table 48. Global Pharmaceutical Intermediates Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Pharmaceutical Intermediates Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Pharmaceutical Intermediates Sales Market Share in Value by Application (2018-2024)
Table 51. Global Pharmaceutical Intermediates Price by Application (2018-2024) & (USD/MT)
Table 52. Global Pharmaceutical Intermediates Sales by Application (2024-2034) & (K MT)
Table 53. Global Pharmaceutical Intermediates Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Pharmaceutical Intermediates Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Pharmaceutical Intermediates Sales Market Share in Value by Application (2024-2034)
Table 56. Global Pharmaceutical Intermediates Price by Application (2024-2034) & (USD/MT)
Table 57. North America Pharmaceutical Intermediates Sales by Application (2018-2024) (K MT)
Table 58. North America Pharmaceutical Intermediates Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Pharmaceutical Intermediates Sales by Application (2018-2024) (K MT)
Table 60. Europe Pharmaceutical Intermediates Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Pharmaceutical Intermediates Sales by Application (2018-2024) (K MT)
Table 62. Asia-Pacific Pharmaceutical Intermediates Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Pharmaceutical Intermediates Sales by Application (2018-2024) (K MT)
Table 64. Latin America Pharmaceutical Intermediates Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2018-2024) (K MT)
Table 66. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Pharmaceutical Intermediates Sales by Country (2018-2024) & (K MT)
Table 68. North America Pharmaceutical Intermediates Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Pharmaceutical Intermediates Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Pharmaceutical Intermediates Sales Market Share in Value by Country (2018-2024)
Table 71. North America Pharmaceutical Intermediates Sales by Country (2024-2034) & (K MT)
Table 72. North America Pharmaceutical Intermediates Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Pharmaceutical Intermediates Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Pharmaceutical Intermediates Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Pharmaceutical Intermediates Sales by Country (2018-2024) & (K MT)
Table 76. Europe Pharmaceutical Intermediates Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Pharmaceutical Intermediates Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Pharmaceutical Intermediates Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Pharmaceutical Intermediates Sales by Country (2024-2034) & (K MT)
Table 80. Europe Pharmaceutical Intermediates Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Pharmaceutical Intermediates Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Pharmaceutical Intermediates Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Pharmaceutical Intermediates Sales by Region (2018-2024) & (K MT)
Table 84. Asia-Pacific Pharmaceutical Intermediates Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Pharmaceutical Intermediates Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Pharmaceutical Intermediates Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Pharmaceutical Intermediates Sales by Region (2024-2034) & (K MT)
Table 88. Asia-Pacific Pharmaceutical Intermediates Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Pharmaceutical Intermediates Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Pharmaceutical Intermediates Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Pharmaceutical Intermediates Sales by Country (2018-2024) & (K MT)
Table 92. Latin America Pharmaceutical Intermediates Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Pharmaceutical Intermediates Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Pharmaceutical Intermediates Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Pharmaceutical Intermediates Sales by Country (2024-2034) & (K MT)
Table 96. Latin America Pharmaceutical Intermediates Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Pharmaceutical Intermediates Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Pharmaceutical Intermediates Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2018-2024) & (K MT)
Table 100. Middle East and Africa Pharmaceutical Intermediates Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Pharmaceutical Intermediates Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2024-2034) & (K MT)
Table 104. Middle East and Africa Pharmaceutical Intermediates Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Pharmaceutical Intermediates Sales Market Share in Value by Country (2024-2034)
Table 107. Lonza Company Information
Table 108. Lonza Introduction and Business Overview
Table 109. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 110. Lonza Pharmaceutical Intermediates Product
Table 111. Lonza Recent Development
Table 112. Catalent Company Information
Table 113. Catalent Introduction and Business Overview
Table 114. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 115. Catalent Pharmaceutical Intermediates Product
Table 116. Catalent Recent Development
Table 117. Patheon Company Information
Table 118. Patheon Introduction and Business Overview
Table 119. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 120. Patheon Pharmaceutical Intermediates Product
Table 121. Patheon Recent Development
Table 122. Jubilant Company Information
Table 123. Jubilant Introduction and Business Overview
Table 124. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 125. Jubilant Pharmaceutical Intermediates Product
Table 126. Jubilant Recent Development
Table 127. Granules Company Information
Table 128. Granules Introduction and Business Overview
Table 129. Granules Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 130. Granules Pharmaceutical Intermediates Product
Table 131. Granules Recent Development
Table 132. Ganesh Company Information
Table 133. Ganesh Introduction and Business Overview
Table 134. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 135. Ganesh Pharmaceutical Intermediates Product
Table 136. Ganesh Recent Development
Table 137. Chemcon Company Information
Table 138. Chemcon Introduction and Business Overview
Table 139. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 140. Chemcon Pharmaceutical Intermediates Product
Table 141. Chemcon Recent Development
Table 142. BASF Company Information
Table 143. BASF Introduction and Business Overview
Table 144. BASF Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 145. BASF Pharmaceutical Intermediates Product
Table 146. BASF Recent Development
Table 147. Porton Company Information
Table 148. Porton Introduction and Business Overview
Table 149. Porton Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 150. Porton Pharmaceutical Intermediates Product
Table 151. Porton Recent Development
Table 152. Lianhetech Company Information
Table 153. Lianhetech Introduction and Business Overview
Table 154. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 155. Lianhetech Pharmaceutical Intermediates Product
Table 156. Lianhetech Recent Development
Table 157. ABA Chem Company Information
Table 158. ABA Chem Introduction and Business Overview
Table 159. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 160. ABA Chem Pharmaceutical Intermediates Product
Table 161. ABA Chem Recent Development
Table 162. Tianma Company Information
Table 163. Tianma Introduction and Business Overview
Table 164. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 165. Tianma Pharmaceutical Intermediates Product
Table 166. Tianma Recent Development
Table 167. Jiujiujiu Company Information
Table 168. Jiujiujiu Introduction and Business Overview
Table 169. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 170. Jiujiujiu Pharmaceutical Intermediates Product
Table 171. Jiujiujiu Recent Development
Table 172. Alpha Company Information
Table 173. Alpha Introduction and Business Overview
Table 174. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 175. Alpha Pharmaceutical Intermediates Product
Table 176. Alpha Recent Development
Table 177. Jiuzhou Company Information
Table 178. Jiuzhou Introduction and Business Overview
Table 179. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 180. Jiuzhou Pharmaceutical Intermediates Product
Table 181. Jiuzhou Recent Development
Table 182. Yongtai Company Information
Table 183. Yongtai Introduction and Business Overview
Table 184. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 185. Yongtai Pharmaceutical Intermediates Product
Table 186. Yongtai Recent Development
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Pharmaceutical Intermediates Market Trends
Table 190. Pharmaceutical Intermediates Market Drivers
Table 191. Pharmaceutical Intermediates Market Challenges
Table 192. Pharmaceutical Intermediates Market Restraints
Table 193. Pharmaceutical Intermediates Distributors List
Table 194. Pharmaceutical Intermediates Downstream Customers
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Intermediates Product Picture
Figure 2. Global Pharmaceutical Intermediates Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Pharmaceutical Intermediates Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Pharmaceutical Intermediates Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of GMP
Figure 6. Global GMP Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Non-GMP
Figure 8. Global Non-GMP Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Global Pharmaceutical Intermediates Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Pharmaceutical Intermediates Sales Market Share by Type in 2022 & 2034
Figure 11. North America Pharmaceutical Intermediates Sales Market Share in Volume by Type in 2022
Figure 12. North America Pharmaceutical Intermediates Sales Market Share in Value by Type in 2022
Figure 13. Europe Pharmaceutical Intermediates Sales Market Share in Volume by Type in 2022
Figure 14. Europe Pharmaceutical Intermediates Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Pharmaceutical Intermediates Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Pharmaceutical Intermediates Sales Market Share in Value by Type in 2022
Figure 17. Latin America Pharmaceutical Intermediates Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Pharmaceutical Intermediates Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Pharmaceutical Intermediates Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Pharmaceutical Intermediates Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharmaceutical Intermediates Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharmaceutical Intermediates Revenue in 2022
Figure 23. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Antibiotics
Figure 25. Global Antibiotics Sales YoY Growth (2018-2034) & (K MT)
Figure 26. Product Picture of Antipyretic Analgesics
Figure 27. Global Antipyretic Analgesics Sales YoY Growth (2018-2034) & (K MT)
Figure 28. Product Picture of Vitamins
Figure 29. Global Vitamins Sales YoY Growth (2018-2034) & (K MT)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2034) & (K MT)
Figure 32. Global Pharmaceutical Intermediates Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Pharmaceutical Intermediates Sales Market Share by Application in 2022 & 2034
Figure 34. North America Pharmaceutical Intermediates Sales Market Share in Volume by Application in 2022
Figure 35. North America Pharmaceutical Intermediates Sales Market Share in Value by Application in 2022
Figure 36. Europe Pharmaceutical Intermediates Sales Market Share in Volume by Application in 2022
Figure 37. Europe Pharmaceutical Intermediates Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Pharmaceutical Intermediates Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Pharmaceutical Intermediates Sales Market Share in Value by Application in 2022
Figure 40. Latin America Pharmaceutical Intermediates Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Pharmaceutical Intermediates Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Pharmaceutical Intermediates Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Pharmaceutical Intermediates Manufacturing Cost Structure
Figure 45. Pharmaceutical Intermediates Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries